[HTML][HTML] Clinical, morphologic and molecular heterogeneity of HPV-associated oropharyngeal cancer
The incidence of human papillomavirus-positive (HPV+) oropharyngeal squamous cell
carcinoma (OPSCC) is rising rapidly and has exceeded cervical cancer to become the most …
carcinoma (OPSCC) is rising rapidly and has exceeded cervical cancer to become the most …
[HTML][HTML] HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management
Abstract Human papillomavirus (HPV)-positive (HPV+) oropharyngeal squamous cell
carcinoma (OPSCC) has one of the most rapidly increasing incidences of any cancer in high …
carcinoma (OPSCC) has one of the most rapidly increasing incidences of any cancer in high …
The role of human papillomavirus on the prognosis and treatment of oropharyngeal carcinoma
Human papillomavirus positive oropharyngeal cancer (HPV-positive OPC) is a distinct
subtype of head and neck carcinoma (HNC) distinguished from HPV-negative HNC by its …
subtype of head and neck carcinoma (HNC) distinguished from HPV-negative HNC by its …
[HTML][HTML] Human papillomavirus-related oropharyngeal cancer
High-risk human papillomavirus (HPV) is now recognised as the principal cause of the
increasing incidence rates of oropharyngeal squamous cell carcinoma (OPSCC) in some …
increasing incidence rates of oropharyngeal squamous cell carcinoma (OPSCC) in some …
Current state of play for HPV-positive oropharyngeal cancers
F Deutsch, IR Bullen, K Nguyen, NH Tran… - Cancer Treatment …, 2022 - Elsevier
Abstracte Clinically, HPV-positive oropharyngeal cancers (OPCs) have been shown to have
a distinct prognosis, compared to HPV-negative tumours, particularly in survival rates and …
a distinct prognosis, compared to HPV-negative tumours, particularly in survival rates and …
Primary chemotherapy and radiation as a treatment strategy for HPV-positive oropharyngeal cancer
VWY Lui, JR Grandis - Head and neck pathology, 2012 - Springer
The incidence of human papillomavirus-positive oropharyngeal cancer (HPV/OPSCC) is
rapidly increasing, which will represent a major public health burden for decades to come …
rapidly increasing, which will represent a major public health burden for decades to come …
[HTML][HTML] HPV-associated oropharyngeal cancer: In search of surrogate biomarkers for early lesions
YX Lim, NJ D'Silva - Oncogene, 2024 - nature.com
The incidence of oropharyngeal cancer (OPSCC) has escalated in the past few decades;
this has largely been triggered by high-risk human papillomavirus (HPV). Early cancer …
this has largely been triggered by high-risk human papillomavirus (HPV). Early cancer …
[HTML][HTML] Oropharyngeal carcinoma with a special focus on HPV-related squamous cell carcinoma
Human papillomavirus–positive oropharyngeal squamous cell carcinoma (HPV-OPSCC)
has one of the most rapidly increasing incidences of any cancer in high-income countries …
has one of the most rapidly increasing incidences of any cancer in high-income countries …
Impact of human papillomavirus on oropharyngeal cancer biology and response to therapy: implications for treatment
J Bonilla-Velez, EA Mroz, RJ Hammon… - … Clinics of North …, 2013 - oto.theclinics.com
Within the recent epidemic of oropharyngeal squamous cell carcinoma (OPSCC), 1 human
papillomavirus (HPV) has been found to play a pivotal role in defining a subset of patients …
papillomavirus (HPV) has been found to play a pivotal role in defining a subset of patients …
Molecular prognostic indicators in HPV-positive oropharyngeal cancer: an updated review
Infection with HPV virus and exposure to extrinsic carcinogens are the main causative
factors for oropharyngeal squamous cell carcinoma (OPSCC). While HPV-related OPSCC …
factors for oropharyngeal squamous cell carcinoma (OPSCC). While HPV-related OPSCC …
相关搜索
- oropharyngeal cancer clinical management
- oropharyngeal cancer molecular biology
- oropharyngeal cancer human papillomavirus
- oropharyngeal cancer surrogate biomarkers
- oropharyngeal cancer treatment strategy
- oropharynx cancer hpv opc
- oropharyngeal cancer early lesions
- oropharyngeal cancer primary chemotherapy
- clinical management molecular biology